IL-2 THERAPY FOR MELANOMA FUNDAMENTALS EXPLAINED

It can be effectively recognized that IL-two is usually a pleiotropic cytokine positioned on the crossroads of T cell activation and regulation. Therefore, it can be crucial to engineer an IL-2 molecule that may be biased towards effector cells bearing the intermediate affinity receptor, such as naïve and memory CD8+ T cells and NK cells, versus T